MediPharm Labs sells Ontario facility for C$5.5M as part of streamlining plan
Kensana wants to use the facility to develop an FDA-approved topical chronic wound treatment.
The post MediPharm Labs sells Ontario facility for C$5.5M as part of streamlining plan appeared first on Green Market Report.
